Pricing Log in Create free account

Pasithea Therapeutics Corp. (KTTA) vs NewcelX Ltd. (NCEL)

Pasithea Therapeutics Corp. and NewcelX Ltd. are both Biotechnology companies. Pasithea Therapeutics Corp. is the larger, with a market value of $17.4M against $15.6M — 1.1× the size. Across the 10 metrics below, NewcelX Ltd. leads on 6 and Pasithea Therapeutics Corp. on 4.

Valuation

Metric KTTA NCEL Biotechnology median
P/E n/m n/m 10.60
P/S 38.26 n/m 9.40
P/B 0.37 5.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 1.17 n/m 0.66
EV/Sales (55.79) n/m 9.02
Earnings yield (254.86%) (56.25%) (32.88%)
Free cash flow yield (94.76%) (16.18%) (23.13%)

Profitability

Metric KTTA NCEL Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.49%) 0.00% (51.96%)
Return on assets (61.97%) 0.00% (46.06%)
Return on invested capital (367.46%) 0.00% 0.00%

Growth

Metric KTTA NCEL Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 77.07% 11.18% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KTTA NCEL Biotechnology median
Debt to equity 0.00 0.06 0.00
Current ratio 26.25 0.40 4.97
Net debt to EBITDA 2.74 0.74 1.01

Dividend

Metric KTTA NCEL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KTTA NCEL Biotechnology median
Market cap 17.38m 15.56m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack